Adding the FcRn antagonist efgartigimod for the prevention of IgG-mediated complications in the peri-transplant period.
Cooper DL, Verceles JA, Kheradmand T, Paroder M, Lombardo A, de Castro A, Browne R, Konopleva M, Moavero B, Goldfinger M, Mantzaris I, Kornblum N, Sica RA, Shastri A, Shapiro LC, Peeke SZ, Gupta R, Gritsman K, Feldman EJ, Verma A.
Cooper DL, et al. Among authors: feldman ej.
Transfusion. 2025 Aug 5. doi: 10.1111/trf.18374. Online ahead of print.
Transfusion. 2025.
PMID: 40765182